[Critics and proposals for the response criteria of the Japan Lung Cancer Society].
The successful conduct of cancer treatment trials is dependent upon the use of consistent criteria for response and for toxicity. In 1982, the Japan Lung Cancer Society published its own criteria which conformed to the response criteria of the Japan Society for Cancer Therapy, with some additional comments for the evaluation of tumors on the chest X-ray. Although the criteria have been used on all studies in Japan and have made a contribution to qualify clinical trials of lung cancer, these criteria must be updated by the introduction of modern techniques such as computerized axial tomography and magnetic resonance imaging. In this paper, the author dare criticized the criteria, referred to points of question and proposed some revisions in a small part of the criteria.
Ohnoshi
T
T
Dept. of Medicine, Okayama University Medical School.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007564:Japan; D008175:Lung Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012955:Societies, Medical
D000970:Antineoplastic Agents